Dermatan sulfate

Star0

DB15880InvestigationalSmall molecule

Dermatan sulfate is a medication indicated to prevent deep vein thrombosis. A medication used to prevent blood clots.

Mechanism: Pharmacologically active on Heparin cofactor 2
Curator reviewed
Formula / weight: C₁₄H₂₁NO₁₅S · 475.38 g/mol (avg)
Also known as: beta-Heparin · Chondroitin sulfate B · Dermatan L-iduronate · Dermatan sulfate, low molecular weight · Dermatan sulphate
Code names: MF-701

Resolves to

Compound

UNIIJ3OC7JVS54CAS24967-94-0

Clinical / RWD

ATCB01AX04

Structure

InChIKeyAVJBPWGFOQAPRH-FWMKGIEWSA-LSMILESCC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@@H]1O[C@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O

Targets

P05546SERPIND1

What you can answer from here — as of July 17, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

642Drug interactionsStructured to mechanism, not free text

2Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

9ContraindicationsEach with its own population and attribute set

5Marketed productsAcross 1 country and 1 labeller

1ATC codeIncluding every combination product, plus 8 drug categories

12+ReferencesStructured and connected to the statements they support

Which drugs share a target with Dermatan sulfate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account